Portugal

Association asks 5% update on generic prices

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 08/10/2026, 10:31:24 UTC.

Briefings

Brazilian pharmaceutical group Equalmed requested a 5% price increase for generic medicines and the removal of an extra contribution to the pharmaceutical industry. This demand was submitted to the government on October 8, 2026, following a period of high inflation affecting drug costs. The request highlights ongoing tensions between the pharmaceutical sector and public health policy in Brazil.

Key points

• Equalmed demands a 5% price increase for generic medicines and the elimination of an extra contribution to the pharmaceutical industry.
• The demand was submitted to the government on October 8, 2026, amidst high inflation affecting drug costs.

Context

Equalmed, a major Brazilian pharmaceutical group, is seeking policy changes to address rising drug prices. This request comes after a period of high inflation that has significantly increased the cost of medicines, creating pressure on the government to intervene.

Limitations

The evidence is limited to the specific demand from Equalmed dated October 8, 2026. No data on the current price levels, the specific pharmaceutical products affected, or the government's response is provided.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 07/11/2026, 12:45:39 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidtrplgmfvdi4orgbxrlyuidpwle3cgv426lxurqe5vyalnrb33sq